Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim

• Adam Al-Hakim,
• Alyssa Cull,
• Joanna Topping,
• Fatima Nadat,
• Joanna Milek,
• Razan Alhefzi,
• Michael F. McDermott,
• Roger Owen,
• Catherine Cargo,
• James Poulter,
• David G. Kent,
• Sinisa Savic,
• on behalf of the ImmunAID consortium*

Affiliations

Adam Al-Hakim

1 Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, United Kingdom

Alyssa Cull

2 Department of Biology, York Biomedical Research Institute, University of York, United Kingdom

Joanna Topping

3 Leeds Institute of Rheumatic and Musculoskeletal Medicine, St. James’s University Hospital, Leeds, United Kingdom

Fatima Nadat

1 Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, United Kingdom

Joanna Milek

2 Department of Biology, York Biomedical Research Institute, University of York, United Kingdom

Razan Alhefzi

2 Department of Biology, York Biomedical Research Institute, University of York, United Kingdom

Michael F. McDermott

3 Leeds Institute of Rheumatic and Musculoskeletal Medicine, St. James’s University Hospital, Leeds, United Kingdom

Roger Owen

4 Haematological Malignancy Diagnostic Service, St James’s University Hospital, Leeds, United Kingdom

Catherine Cargo

4 Haematological Malignancy Diagnostic Service, St James’s University Hospital, Leeds, United Kingdom

James Poulter

5 Leeds Institute of Medical Research, St. James’s University Hospital, Leeds, United Kingdom

David G. Kent

2 Department of Biology, York Biomedical Research Institute, University of York, United Kingdom

Sinisa Savic

1 Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, United Kingdom

on behalf of the ImmunAID consortium*